I remember interviewing there during the peak hype (late 2015). Crazy environment. According to Crunchbase they havent raised a round since then. I would guess

I remember interviewing there during the peak hype (late 2015). Crazy environment. According to Crunchbase they havent raised a round since then. I would guess the main reason we haven't heard much is: * The ACA employer mandate has been at risk for the past couple of years, which was one of the main drivers of their business model * They seem to have moved to a more standard SaaS model rather than giving the software away for free and making money on health insurance commissions. * The CEO turmoil and regulatory issues caused them to keep a low profile. Overall I think the Series C valuation is at serious risk, but the overall business would be profitable.